Pharmaceutical aerosol containing at least one sugar
Patent 5955439 Issued on September 21, 1999. Estimated Expiration Date: 
June 24, 2017. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.
June 24, 2017. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.InventorAssigneeApplicationNo. 849538 filed on 06/24/1997US Classes:514/23, Carbohydrate (i.e., saccharide radical containing) DOAI424/45, Organic pressurized fluid424/46, Powder or dust containing424/489, Particulate form (e.g., powders, granules, beads, microcapsules, and pellets)424/499, Contains proteins or derivative or polysaccharides or derivative514/174, -O-C-O- is part of a hetero ring (e.g., acetonide, etc.)514/178, Oxygen single bonded to a ring carbon of the cyclopentanohydrophenanthrene ring system514/180, 9-position substituted514/357, Nitrogen attached indirectly to the six-membered hetero ring by nonionic bonding514/653, Hydroxy, bonded directly to carbon, attached directly or indirectly to the acyclic carbon or chain by acyclic nonionic bonding (e.g., beta hydroxy phenethylamines, etc.)514/757, Two or more halogenated hydrocarbons514/758, Chlorine as only halogen514/759, Fluorine as only halogen604/890.1CONTROLLED RELEASE THERAPEUTIC DEVICE OR SYSTEMExaminersPrimary: Cook, RebeccaAttorney, Agent or FirmForeign Patent References
International ClassesA01N 043/04A61K 031/56 A61K 031/70 Foreign Application Priority Data1994-12-24 GBAbstractThis invention relates to aerosol formulations of use for the administration of medicaments by inhalation and in particular to a pharmaceutical aerosol formulation which comprises (a) particulate medicament; (b) at least one sugar; and (c) a fluorocarbon or hydrogen-containing chlorofluorocarbon propellant. A method of treating respiratory disorders which comprises administration by inhalation of an effective amount of a pharmaceutical aerosol formulation as defined is also described.Other References
Field of SearchFluorine as only halogenOxygen single bonded to a ring carbon of the cyclopentanohydrophenanthrene ring system Carbohydrate (i.e., saccharide radical containing) DOAI Chlorine as only halogen -O-C-O- is part of a hetero ring (e.g., acetonide, etc.) 9-position substituted Hydroxy, bonded directly to carbon, attached directly or indirectly to the acyclic carbon or chain by acyclic nonionic bonding (e.g., beta hydroxy phenethylamines, etc.) Nitrogen attached indirectly to the six-membered hetero ring by nonionic bonding Organic pressurized fluid Powder or dust containing Particulate form (e.g., powders, granules, beads, microcapsules, and pellets) Contains proteins or derivative or polysaccharides or derivative CONTROLLED RELEASE THERAPEUTIC DEVICE OR SYSTEM | |
